Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-04-12
DOI
10.1002/ijc.32325
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
- (2017) Abhishek D. Garg et al. TRENDS IN IMMUNOLOGY
- Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
- (2017) Sonja I. Buschow et al. Oncotarget
- Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate
- (2016) Sylvain Ladoire et al. OncoImmunology
- Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy
- (2016) Catherine Dold et al. Molecular Therapy-Oncolytics
- Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
- (2014) A. Muik et al. CANCER RESEARCH
- NK Cells Are Required for Dendritic Cell-Based Immunotherapy at the Time of Tumor Challenge
- (2014) A. L. Bouwer et al. JOURNAL OF IMMUNOLOGY
- VSV-GP: a Potent Viral Vaccine Vector That Boosts the Immune Response upon Repeated Applications
- (2014) R. Tober et al. JOURNAL OF VIROLOGY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Deciphering and Reversing Tumor Immune Suppression
- (2013) Greg T. Motz et al. IMMUNITY
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
- (2012) Eva Ellebaek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Vesicular Stomatitis Virus Oncolytic Treatment Interferes with Tumor-Associated Dendritic Cell Functions and Abrogates Tumor Antigen Presentation
- (2011) S. Leveille et al. JOURNAL OF VIROLOGY
- Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism
- (2011) A. Muik et al. JOURNAL OF VIROLOGY
- Type III IFN Interleukin-28 Mediates the Antitumor Efficacy of Oncolytic Virus VSV in Immune-Competent Mouse Models of Cancer
- (2010) Phonphimon Wongthida et al. CANCER RESEARCH
- Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
- (2010) Nikolaus Romani et al. IMMUNOLOGY AND CELL BIOLOGY
- Conditioning of the Injection Site With CpG Enhances the Migration of Adoptively Transferred Dendritic Cells and Endogenous CD8+ T-cell Responses
- (2010) Christoph H. Tripp et al. JOURNAL OF IMMUNOTHERAPY
- Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy
- (2010) Paul T Sobol et al. MOLECULAR THERAPY
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma
- (2009) F Galivo et al. GENE THERAPY
- Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
- (2009) Feorillo Galivo et al. HUMAN GENE THERAPY
- Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
- (2008) Ninke Leffers et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
- (2008) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
- rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy
- (2008) Lan Wu et al. HUMAN GENE THERAPY
- Exponential Enhancement of Oncolytic Vesicular Stomatitis Virus Potency by Vector-mediated Suppression of Inflammatory Responses In Vivo
- (2007) Jennifer Altomonte et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started